PRF Technologies Ltd.(PRFX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
PRFX Stock Analysis & AI Quality Score
AI stock analysis and institutional research for PRF Technologies Ltd. (PRFX), a Healthcare sector company. PRFX is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Based on the latest XBRL financial filings (FY 2025), PRF Technologies Ltd. reports quarterly revenue of $17.0K, net income of $-5.0M, free cash flow of $-4.0M. Top institutional holders of PRFX by reported 13-F value include MORGAN STANLEY, TWO SIGMA SECURITIES,, XTX Topco Ltd, based on the most recent SEC filings. PRFX trades on the Nasdaq exchange and files with the SEC under CIK 1801834. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PRFX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for PRF Technologies Ltd. directly from SEC EDGAR.
Revenue
FY 2025
$17.0K
Net Income
FY 2025
$-5.0M
Free Cash Flow
FY 2025
$-4.0M
ROIC
FY 2025
-60.0%
AI Insight: PRFX Financial Trends
Equity staged a partial recovery to $9M in Q4 2025, but remains well below the $15M peak seen in Q2 2022.
• Equity eroded steadily from $15M in Q2 2022 to a negative $-2M in Q2 2024, signaling a multi-year balance sheet deterioration.
• Equity rebounded from $-2M in Q2 2024 to $9M in Q4 2025, a $11M recovery over five quarters.
⚠ Revenue, earnings, cash flow, and debt data are entirely absent — trend quality is severely limited to equity alone.
⚠ Equity at $9M remains 40% below Q2 2022 levels; durability of the recovery is unverifiable without income or cash flow data.
AI Insight: PRFX Ratio Trends
Insufficient data — no financial ratios are available for PRFX across any reported period.
• All ratio fields are blank across every period from Q2 2022 through Q4 2025; no trends can be derived.
⚠ Monitor for first disclosure of margin and return metrics before drawing any fundamental conclusions.
Get alerted when PRFX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for PRF Technologies Ltd. including:
Top Institutional Holders of PRFX
MORGAN STANLEY
$16.4K25,602 shTWO SIGMA SECURITIES, LLC
$13.7K21,344 shXTX Topco Ltd
$8.6K13,460 shUBS Group AG
$2.8K4,339 shOSAIC HOLDINGS, INC.
$121.00193 shSBI Securities Co., Ltd.
$4.006 sh
| Fund | Value | Shares |
|---|---|---|
| MORGAN STANLEY | $16.4K | 25,602 |
| TWO SIGMA SECURITIES, LLC | $13.7K | 21,344 |
| XTX Topco Ltd | $8.6K | 13,460 |
| UBS Group AG | $2.8K | 4,339 |
| OSAIC HOLDINGS, INC. | $121.00 | 193 |
| SBI Securities Co., Ltd. | $4.00 | 6 |
More Healthcare Companies
View all Healthcare →Put PRFX on your watchlist
Track score changes the day PRF Technologies Ltd. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is PRFX a good stock to buy?
13F Pro's AI-powered analysis of PRF Technologies Ltd. (PRFX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for PRFX are available on the PRFX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own PRFX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling PRFX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of PRF Technologies Ltd.'s investment landscape.